Latest Down's Syndrome Stories
Scientists at the University of Massachusetts Medical School have made a huge breakthrough in our understanding of Down's syndrome.
Researchers are now finding links between Downâ€™s syndrome and drugs used in in-vitro fertilization (IVF) for older women.
A test that uses the latest DNA technology to analyze genetic components in a pregnant woman's blood could predict Down's syndrome in unborn babies, according to new research.
Researchers say that a blood test during pregnancy could one day replace more invasive tests for Down's syndrome.
Research undertaken in recent years on Downâ€™s syndrome has focused on the DYRK1A gene.
A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down\'s syndrome.
A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.
A new national screening strategy in Denmark has halved the number of infants born with Down's syndrome and increased the number of infants diagnosed before birth by 30%, according to a study published on bmj.com today.
Scientists say a prenatal blood test can determine if an unborn baby has Downâ€™s syndrome, without the risk to the fetus from past invasive testing methods, according to US researchers.
Antenatal screening services for conditions such as Down's syndrome do not always give parents the time needed to make decisions about their unborn babies, according to work done by Plymouth researchers.
- a meat pie that is usually eaten at Christmas in Quebec